The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
Claims What is claimed is: 1. An isolated polypeptide selected from the group consisting of: a) a polypeptide which is encoded by a nucleic acid comprising the nucleotide sequence of SEQ ID NO:5; and b) a polypeptide comprising the amino acid sequence of SEQ ID NO:4. 2. The polypeptide of claim 1 wherein the polypeptide is encoded by a nucleic acid comprising the nucleotide sequence of SEQ ID NO:5. 3. The polypeptide of claim 1, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:4. 4. The polypeptide of claim 1, wherein the polypeptide is encoded by a nucleic acid consisting of the nucleotide sequence of SEQ ID NO:5. 5. The polypeptide of claim 1, wherein the polypeptide consists of the amino acid sequence of SEQ ID NO:4. 6. A fusion protein comprising the polypeptide of claim 1, wherein the fusion protein has ubiquitin protease activity. 7. A fusion protein comprising the polypeptide of claim 2, wherein the fusion protein has ubiquitin protease activity. 8. A fusion protein comprising the polypeptide of claim 3, wherein the fusion protein has ubiquitin protease activity. 9. A fusion protein comprising the polypeptide of claim 4, wherein the fusion protein has ubiquitin protease activity. 10. A fusion protein comprising the polypeptide of claim 5, wherein the fusion protein has ubiquitin protease activity. 